Game Changers to help women promote cervical cancer screening in Uganda
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
A peer-led program trains women who were screened to encourage friends and family to get cervical cancer screening in Uganda.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-11404687 on NIH RePORTER |
What this research studies
You would be part of a community program where women who recently had cervical screening lead seven group sessions to share knowledge, dispel myths, and reduce stigma about screening. Those trained peers are supported to talk with women in their social networks and encourage them to get visual inspection with acetic acid (VIA) screening. The research team will compare communities where the program is offered to others to see whether more women get screened and whether the approach can be kept going over time. The work builds on a small pilot that showed much higher screening among people reached through peers.
Who could benefit from this research
Good fit: Women in Uganda who are eligible for cervical cancer screening or women who have recently been screened and want to serve as peer leaders are ideal candidates.
Not a fit: People who do not live in participating Ugandan communities, men, or women who already get regular screening are unlikely to benefit directly from joining this program.
Why it matters
Potential benefit: If successful, the program could increase screening so more cancers are caught earlier and fewer women present with advanced disease.
How similar studies have performed: A prior pilot randomized trial funded by an R21 showed dramatic increases in screening among social network members reached by the peer-led intervention.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Wagner, Glenn John — Rand Corporation
- Study coordinator: Wagner, Glenn John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.